Bill Text: IA SF329 | 2015-2016 | 86th General Assembly | Introduced
Bill Title: A bill for an act relating to hospital and long-term care pharmacy practice for pneumococcal vaccines. (Formerly SSB 1198.)
Sponsorship: Committee Bill
Status: (Engrossed - Dead) 2016-01-21 - Subcommittee, Forristall, Anderson, and Fry. H.J. 104. [SF329 Detail]
Download: Iowa-2015-SF329-Introduced.html
Senate File 329 - Introduced SENATE FILE BY COMMITTEE ON HUMAN RESOURCES (SUCCESSOR TO SSB 1198) A BILL FOR 1 An Act relating to hospital and long=term care pharmacy 2 practice for pneumococcal vaccines. 3 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: TLSB 2385SV (1) 86 pf/nh PAG LIN 1 1 Section 1. HOSPITAL AND LONG=TERM CARE PHARMACY PRACTICE == 1 2 PNEUMOCOCCAL VACCINES == BOARD OF PHARMACY RULES. The board 1 3 of pharmacy shall adopt rules pursuant to chapter 17A relating 1 4 to hospital and long=term care pharmacy practices that allow, 1 5 as authorized by federal law, that in addition to influenza 1 6 and pneumococcal polysaccharide vaccines, a written or verbal 1 7 patient=specific medication administration order shall not 1 8 be required prior to administration to an adult patient of 1 9 pneumococcal conjugate vaccine pursuant to physician=approved 1 10 hospital or facility policy and after the patient has been 1 11 assessed for contraindications. 1 12 EXPLANATION 1 13 The inclusion of this explanation does not constitute agreement with 1 14 the explanation's substance by the members of the general assembly. 1 15 This bill directs the board of pharmacy to adopt rules 1 16 pursuant to chapter 17A relating to hospital and long=term 1 17 care pharmacy practice that allow, as authorized by 1 18 federal law, that in addition to influenza and pneumococcal 1 19 polysaccharide vaccines, a written or verbal patient=specific 1 20 medication administration order shall not be required 1 21 prior to administration to an adult patient of pneumococcal 1 22 conjugate vaccine pursuant to physician=approved hospital or 1 23 facility policy and after the patient has been assessed for 1 24 contraindications. LSB 2385SV (1) 86 pf/nh
